We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Drugs that prolong the QT interval may increase the risk ...
Communicating With Realism and Hope: Incurable Cancer Patients' Views on the Disclosure of Prognosis 5-Hydroxytryptamine-3 receptor antagonists (5-HT 3 antagonists) are effective for preventing acute ...
Clinical applications of hematopoietic growth factors. Comparison data used are the preclinical pharmacology as well as the design and results of clinical trials. Seven comparative studies that used ...
In a Review published in the February 2008 issue of Nature Clinical Practice Rheumatology, Riley discussed the molecular pathology of tendinopathy and novel and specific molecular targets for therapy.
Nat Clin Pract Oncol. 2005;2(4):196-201. In all three studies, antiemetic treatment was well tolerated with no significant differences in the frequency of adverse events between the three arms. The ...
Sugar consumption has increased markedly over the last few decades and parallels the dramatic increase in overweight and obesity. Data obtained from animal studies suggest that the intestinal ...
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections Raichur & Hyderabad, India – ...
BARCELONA-LUGANO, 1 July 2015 - The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin chemotherapy, antiemetics expert and ESMO ...
Ongoing development of new antiemetic drugs in recent years has provided us with a number of effective new agents. These compounds provide an opportunity to further improve the control of CINV in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results